Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04187105 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Eligibility criteria expanded, about 23 wordsv11 See this version in full on ClinicalTrials.gov ↗
  2. Primary endpoints: 2 to 1 Interventions: Arm 1 (Device), Arm1 (Device), Arm1 (Drug), Arm1 (Drug), Arm1 (Drug), Arm1 (Drug), Arm1 (Other) to Conditioning regimen with half-matched (haploidentical) stem cell transplant (Device), Conditioning regimen with half-matched… · Eligibility criteria expanded, about 7 words · Secondary endpoints: details revised at 9 of 9 entries · 2 morev10 Show 5 more changesShow less
    • Interventions: Arm 1 (Device), Arm1 (Device), Arm1 (Drug), Arm1 (Drug), Arm1 (Drug), Arm1 (Drug), Arm1 (Other) to Conditioning regimen with half-matched (haploidentical) stem cell transplant (Device), Conditioning regimen with half-matched…
    • Eligibility criteria expanded, about 7 words
    • Secondary endpoints: details revised at 9 of 9 entries
    • Study description expanded, about 17 words
    • Study arms: 0 to 1

    See this version in full on ClinicalTrials.gov ↗

  3. Primary and study completion dates: Nov 2024 to Dec 2026v9
  4. 2 versions Re-verified since Sep 7, 2023, no change to tracked fieldsv7-v8
  5. Site contact updatedv6
Show 4 earlier versionsHide 4 earlier versions
  1. Re-verified, no change to tracked fieldsv5
  2. Start date: Nov 8, 2019 to Jan 27, 2020v4
  3. Secondary endpoints: details revised at 1 of 9 entriesv3
  4. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is being done to see if the addition of a targeted form of radiation to standard conditioning regimen will increase the amount of cancer cells that are killed off in the bone marrow and reduce the chances that your disease may return. This description is called Intensity Modulated Total Marrow Irradiation (IM-TMI).
Trial Details
NCT Number NCT04187105
Lead Sponsor University of Illinois at Chicago
Conditions Acute Leukemia, MDS
Enrollment 27 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov